TY - JOUR
T1 - What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
AU - for the
AU - STASH Collaborators
AU - STASH Collaborators
AU - Teo, Mario
AU - Teo, Mario
AU - Guilfoyle, Mathew R.
AU - Kirkpatrick, Peter J.
AU - Kirkpatrick, Peter J.
AU - Turner, Carole L.
AU - Murray, Gordon D.
AU - Hutchinson, Peter J.
AU - Teasdale, Graham
AU - Murray, Gordon D.
AU - Kirkpatrick, Peter J.
AU - Mendelow, A. David
AU - Muir, Keith
AU - Smith, Martin
AU - McCabe, Peter
AU - Pearson, Jeremy
AU - Ford, Gary
AU - Vail, Andrew
AU - King, Andrew
AU - Tyrrell, Pippa
AU - Richards, Hugh
AU - Bond, Simon
AU - Kirkpatrick, Peter J.
AU - Turner, Carole L.
AU - Smith, Christopher
AU - Warburton, Elizabeth
AU - Kirkpatrick, Peter J.
AU - Turner, Carole L.
AU - Smith, Christopher
AU - Tseng, Ming
AU - Bulters, Diederik
AU - Brown, Martina
AU - Critchley, Giles
AU - Spurling, Gavin
AU - Gaylard, Jane
AU - Javadpour, Mohsen
AU - Eldridge, Paul
AU - Murray, Lorna
AU - Nelson, Richard
AU - Taylor, Ros
AU - Hierons, Sarah
AU - Mendelow, A. David
AU - Tobin, Bianca
AU - Storey, Kelley
AU - Walsh, Daniel
AU - Mistry, Bejal
AU - Aeron-Thomas, John
AU - Puppo, Corina
AU - Papadopoulos, Mario
AU - Whitfield, Peter
N1 - Publisher Copyright:
© 2017
PY - 2017/9
Y1 - 2017/9
N2 - Background The management of aneurysmal subarachnoid hemorrhage (aSAH) has changed dramatically in the last few decades with the publication of a few major studies, including ISAT (International Subarachnoid Aneurysm Trial, the International Cooperative Study on the Timing of Aneurysm Surgery Study). The aim of this study is to analyze the outcome of patients with aSAH based on a contemporary series, identify the risk factors for poor outcome, and focus on patients with good-grade aSAH (to match the ISAT cohort). Methods Baseline demographic and outcome data (modified Rankin Scale) were available for the 803 patients recruited from the STASH (Simvastatin in Aneurysmal Subarachnoid Haemorrhage) trial for post hoc analysis, using a χ2 test or 2-sample t test. Logistic regression analysis was performed to assess the risk factors for poor outcome at 6 months. Propensity matched analysis comparing coiling and clipping, and subgroup analysis of good-grade patients (World Federation of Neurosurgical Societies grade I–II) were also performed. Results Logistic regression analysis showed that the treatment modality (i.e., coiling or clipping) was not associated with poor outcome at 6 months (P = 0.839). The risk factors associated with poor outcome at 6 months were poor admission World Federation of Neurosurgical Societies grade (P < 0.0001), Fisher grade on initial computed tomography scan (P = 0.013), and the development of delayed cerebral ischemia (P < 0.0001). Subgroup analysis for good-grade patients only showed that 82% of patients after coiling and 78% of patients after clipping were classed as good outcome at 6 months (P = 0.181). Conclusions In the current era of aSAH management, apart from patients’ admission status, SAH blood load and the development of delayed cerebral ischemia, treatment modality with either coiling or clipping was not associated with poor outcome difference at 6 months.
AB - Background The management of aneurysmal subarachnoid hemorrhage (aSAH) has changed dramatically in the last few decades with the publication of a few major studies, including ISAT (International Subarachnoid Aneurysm Trial, the International Cooperative Study on the Timing of Aneurysm Surgery Study). The aim of this study is to analyze the outcome of patients with aSAH based on a contemporary series, identify the risk factors for poor outcome, and focus on patients with good-grade aSAH (to match the ISAT cohort). Methods Baseline demographic and outcome data (modified Rankin Scale) were available for the 803 patients recruited from the STASH (Simvastatin in Aneurysmal Subarachnoid Haemorrhage) trial for post hoc analysis, using a χ2 test or 2-sample t test. Logistic regression analysis was performed to assess the risk factors for poor outcome at 6 months. Propensity matched analysis comparing coiling and clipping, and subgroup analysis of good-grade patients (World Federation of Neurosurgical Societies grade I–II) were also performed. Results Logistic regression analysis showed that the treatment modality (i.e., coiling or clipping) was not associated with poor outcome at 6 months (P = 0.839). The risk factors associated with poor outcome at 6 months were poor admission World Federation of Neurosurgical Societies grade (P < 0.0001), Fisher grade on initial computed tomography scan (P = 0.013), and the development of delayed cerebral ischemia (P < 0.0001). Subgroup analysis for good-grade patients only showed that 82% of patients after coiling and 78% of patients after clipping were classed as good outcome at 6 months (P = 0.181). Conclusions In the current era of aSAH management, apart from patients’ admission status, SAH blood load and the development of delayed cerebral ischemia, treatment modality with either coiling or clipping was not associated with poor outcome difference at 6 months.
KW - aSAH
KW - Endovascular coiling
KW - Neurosurgical clipping
KW - Post hoc analysis
KW - Propensity matched analysis
UR - http://www.scopus.com/inward/record.url?scp=85021158731&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2017.05.005
DO - 10.1016/j.wneu.2017.05.005
M3 - Article
C2 - 28502692
AN - SCOPUS:85021158731
SN - 1878-8750
VL - 105
SP - 270
EP - 281
JO - World Neurosurgery
JF - World Neurosurgery
ER -